✦ LIBER ✦

PMC7 THE USE OF DISEASE TRANSMISSION MODELLING IN COST-EFFECTIVENESS ANALYSES: STRENGTHS AND WEAKNESSES

✍ Scribed by RJ Pitman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Challenges in Modelling the Cost Effecti

✍ Burgers, L.T.; Redekop, W.K.; Severens, J.L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PMC18 CONCEPTUALISING DISEASE: BUILDING

✍ D Wild; A Nixon; M Sculpher; A Lloyd; A Briggs; S Mealing; K Gallop 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

The cost-burden of paediatric pneumococc

✍ Sven Arne Silfverdal; Stefan Berg; Claes Hemlin; Iiro Jokinen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 794 KB

MO5 THE USE OF SURVIVAL ANALYSES FOR COS

✍ P Guyot; M Ouwens 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Economics of chronic diseases protocol:

✍ Divajeva, Diana; Marsh, Tim; Logstrup, Susanne; Kestens, Marleen; Vemer, Pepijn; 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 178 KB

SURROGATE, FRIEND OR FOE? THE NEED FOR C

✍ O. Ciani; R. S. Taylor 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB